HealthPhoto: Hindu HealthUK Approves J&J's Oral Pill for Moderate-to-Severe Psoriasis
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved Johnson & Johnson's daily oral pill, Icotyde, for treating moderate-to-severe plaque psoriasis in adults and teenagers aged 12 and above weighing at least 40 kg. Approval was based on four late-stage trials involving 2,500 patients, including 72 teenagers, showing better results after 16 weeks compared to placebo.
Hindu Health·


